NCT06577363View on ClinicalTrials.gov

A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection

RecruitingOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

August 30, 2031

Study Completion Date

August 30, 2031

Conditions

Cytomegalovirus (CMV)

Interventions

DRUG

Maribavir

Maribavir tablets

Trial Locations (1)

Unknown

RECRUITING

Takeda selected site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY